Long-term effects of syringe exchange on risk behavior and HIV prevention

AIDS Education and Prevention

Volumn 16, Issue 3, 2004, Pages 264-275

  Braine, Naomi ^a   Des Jarlais, Don C ^a   Ahmad, Seema ^a   Purchase, Dave ^b   Turner, Charles ^c,d  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b N American Syringe Exchange Network   (United States)

^c RTI INTERNATIONAL   (United States)

^d CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE;

ADULT; ARTICLE; DEPRESSION; DRUG DEPENDENCE; FEMALE; HEALTH BEHAVIOR; HIGH RISK POPULATION; HOMELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION PROCESSING; INJECTION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; SYRINGE; UNITED STATES;

ADULT; FEMALE; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MALE; NEEDLE SHARING; NEEDLE-EXCHANGE PROGRAMS; POVERTY; PROGRAM EVALUATION; RISK-TAKING; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; UNITED STATES;

EID: 3042683461     PISSN: 08999546     EISSN: None     Source Type: Journal    
DOI: 10.1521/aeap.16.3.264.35436     Document Type: Article

References (37)

1. Anderson, T., Shannon, C., Schyb, I., & Goldstein, P. (2002) Welfare reform and housing: Assessing the impact to substance abusers. Journal of Drug Issues, 32(1), 265-296.
2. Beardsley, M., Deren, S., Tortu, S., Goldstein, M.F., Ziek K., & Hamid, R. (1999). Trends in injection risk behaviors in a sample of New York City injection drug users: 1992-1995. Journal of Acquired Immune Deficiency Syndromes, 20, 283-289.
3. Bluthenthal, R.N., Kral, A.H., Gee, L., Erringer, E.A., & Edlin, B.R. (2000). The effect of syringe exchange use on high-risk injection drug users: a cohort study. AIDS, 14, 605-611.
4. Bluthenthal, R.N., Kral, A.H., Gee, L., Lorvick, J., Moore, L., Seal, K., et al. (2001). Trends in HIV seroprevalence and risk among gay and bisexual men who inject drugs in San Francisco, 1988 to 2000. Journal of Acquired Immune Deficiency Syndromes, 28, 264-269.
5. Des Jarlais, D.C., Dehne, K., & Casabonda, J. (2001). HIV surveillance among injecting drug users. AIDS, 15(Suppl. 3), S13-S22.
6. Des Jarlais, D.C., Marmor, M., Paone, D., Titus, S., Shi, Q., Perlis, T., et al. (1996). HIV Incidence among injecting drug users in New York City syringe exchange programmes. The Lancet, 348, 987-991
7. Des Jarlais, D.C., Paone, D., Milliken, J., Turner, C., Miller, H., Gribble, J., et al. (1999). Audio-computer interviewing to measure risk behavior for HIV among injecting drug users: a quasi-randomised trial. The Lancet, 353, 1657-1661.
8. Des Jarlais, D.C., Hagan, H., Friedman, S.R., Friedmann, P., Goldberg, D., Frischer, M., et al. (1995). Maintaining low HIV seroprevalence in populations of injecting drug users. Journal of the American Medical Association, 274, 1226-1231.
9. Ekstrand M.L., Stall, R.D., Paul, J.P., Osmond, D.H., & Coates, T.J. (1999). Gay men report high rates of unprotected anal sex with partners of unknown or discordant HIV status. AIDS, 13, 1525-1533.
10. Evans, J.L., Hahn, J.A., Page-Shafer, K., Lum, P.J., Stein E.S., Davidson, P.J., et al. (2003). Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). Journal of Urban Health, 80, 137-146.
11. Friedman, S.R., Chapman, T.F., Perlis, T.E., Rockwell, R., Paone, D., Sotheran, J.L., et al. (1999). Similarities and differences by race/ethnicity in changes of HIV seroprevalence and related behaviors among drug injectors in New York City, 1991-1996. Journal of Acquired Immune Deficiency Syndromes, 22, 83-91.
12. Gibson, D.R., Brand, R., Anderson, K., Kahn, J.G., Perales, D., & Guydish, J. (2002). Two-to-sixfold decreased odds HIV risk behavior associated with use of syringe programs, Journal of Acquired Immune Deficiency Syndromes, 31, 237-242.
13. Hagan, H., Des Jarlais, D.C., Friedman, S.R., Purchase, D., & Alter, M.J. (1995). Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. American Journal of Public Health, 85, 1531-1537.
14. Hagan, H., Des Jarlais, D.C., Purchase, D., Reid, T., & Friedman, S.R. (1991). The Tacoma Syringe Exchange. Journal of Addiction Disorders, 10, 81-88.
15. Hagan, H., & Thiede, H. (2000). Changes in injection risk behavior associated with participation in the Seattle needle-exchange program. Journal of Urban Health, 77, 369-382.
16. Heimer, R., Khoshnood, K., Bigg, D., Guydish,J., & Junge, B. (1998). Syringe use and reuse: Effects of syringe exchange programs in four cities. Journal of Acquired Immune Deficiency Syndromes, 18(Suppl. 1), S37-S44.
17. Hepatitis B vaccination for injection drug users-Pierce County, Washington, 2000. (2001). Morbidity and Mortality Weekly Report, 50, 388-390, 399.
18. Huebner, D.M., & Gerend, M.A. (2001). The relations between beliefs about drug treatments for HIV and sexual risk behavior in gay and bisexual men. Annals of Behavioral Medicine, 23, 304-312.
19. Johnson, M.E., Yep, M.J., Brems, C., Theno, S.A., & Fisher, D.G. (2002). Relationship among gender, depression, and needle sharing in a sample of injection drug users, Psychology of Addictive Behavior, 164, 338-341.
20. Joseph, H., & Paone, D. (1992). The homeless. In J.H. Lowinson, P. Ruiz, R.B. Millman, & J.G. Langrod (Eds.), Substance Abuse: A Comprehensive Textbook (pp. 733-743). Baltimore: Williams & Wilkins.
21. Kral, A.H., Lorvick, J., & Edlin, B.R. (2000). Sex- and drug-related risk among populations of younger and older injection drug users in adjacent neighborhoods in San Francisco. Journal of Acquired Immune Deficiency Syndromes, 24, 162-167.
22. Longshore, D., Bluthenthal, R.N., & Stein, M.D. (2001). Needle exchange program attendance and injection risk in Providence, Rhode Island. AIDS Education and Prevention, 13, 78-90.
23. Mandell, W., Kim, J., Latkin, C., & Suh, T. (1999). Depressive symptoms drug network, and their synergistic effect on needle-sharing behavior among street injection drug users. American Journal of Drug and Alcohol Abuse, 25, 117-127.
24. Maslow, C.B., Friedman, S.R., Perlis, T.E., Rockwell, R., & Des Jarlais, D.C. (2002). Changes in HIV seroprevalence and related behaviors among male injection drug users who do and do not have sex with men: New York City, 1990-1999. American Journal of Public Health, 92, 382-384.
25. Monterroso, E.R., Hamburger, M.E., Vlahov, D., Des Jarlais, D.C., Ouellet, L.J., Altice, F.L., et al. (2000). Prevention of HIV infection in street-recruited injection drug users. The Collaborative Injection Drug User Study (CIDUS). Journal of Acquired Immune Deficiency Syndromes, 25, 63-70.
26. Montgomery, S.B., Hyde, J., De Rosa, C.J., Rohrbach, L.A., Ennett, S., Harvey, S.M., et al. (2002). Gender differences in HIV risk behaviors among young injectors and their social network members. American Journal of Drug and Alcohol Abuse, 28, 453-475.
27. Neumann, M.S., Johnson, W.D., Semaan, S., Flores, S.A., Peersman, G., Hedges, L.V., et al. (2002). Review and meta-analysis of HIV prevention intervention research for heterosexual adult populations in the United States. Journal of Acquired Immune Deficiency Syndromes, 30, S106-S117.
28. Oggins, J. & Fleming, A. (2001) Welfare reform sanctions and financial strain in a food pantry sample. Journal of Sociology and Social Welfare, 28(2), 101-123.
29. Paone, D., Des Jarlais, D.C., Caloir S., Jose, B., Shi, Q., & Friedman, S.R. (1997). Continued risky injection subsequent to syringe exchange use among injection drug users in New York City. AIDS Education and Prevention, 9, 505-510.
30. Paone, D., Des Jarlais, D.C., Gangloff, R., Milliken, J., & Friedman, S.R. (1995). Syringe exchange: HIV prevention, key findings, and future directions. International Journal of Addictions, 30, 1647-1683.
31. Perdue, T., Hagan H., Thiede, H., & Valleroy, L. (2003). Depression and HIV risk behavior Among Seattle-area injection drug users and young men who have sex with men, AIDS Education and Prevention, 15, 81-92.
32. Purchase, D., Mottram, K., Miron, C., Sharma, D., Cruz-Uribe, F., McInelly, S., & Kobayshi, J. (2001). Hepatities B vaccination for injection drug users-Pierce County, Washington, 2000. Morbidity and Mortality Weekly Report, 50(19), 388-390, 399.
33. Shafer, K.P., Hahn, J.A., Lum, P. J., Ochoa, K., Graves, A., & Moss, A. (2002). Prevalence and Correlates of HIV infection among young injection drug users in San Francisco. Journal of Acquired Immune Deficiency Syndromes, 31, 422-431.
34. Stall, R.D., Hays, R.B., Waldo, C.R., Ekstrand, M., McFarland, W. (2000). The gay '90s: A review of research in the 1990s on sexual behavior and HIV risk among men who have sex with men. AIDS, 14(Suppl. 3), S101-S114.
35. Stolte, I.G., Dukers, N.H., de Wit, J.B., Fennema, J.S., & Coutinho, R.A. (2000). Increase in sexually transmitted infections among homosexual men in Amsterdam in relation to HAART. Sexually Transmitted Infections, 77, 184-186.
36. Tun, W., Celentano, D.D., Vlahov, D., & Strathdee, S. (2003). Attitudes toward HIV treatments influence unsafe sexual and injection practices among injection drug users. AIDS, 17, 1953-1962.
37. Vlahov, D., & Junge, B. (1998). The role of needle exchange programs in HIV prevention. Public Health Report, 113(Suppl. 1), 75-80.